5 Key Takeaways
-
1
Neurotrophic keratitis (NK) can lead to severe visual impairment if not diagnosed and treated early.
-
2
The Mackie classification system stages NK from punctate keratopathy to corneal ulceration and perforation.
-
3
Cryopreserved amniotic membrane (CAM) is the first-line therapy for early NK, promoting nerve regeneration.
-
4
Cenegermin, a nerve growth factor, is effective for advanced NK but may face insurance authorization delays.
-
5
Long-term management of NK requires patient education, adherence to treatment, and addressing underlying conditions.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.